Loading insider details...
Beta
Latest Form 4 (Sep 25, 2026): Disposition to Issuer of 58,065 TBPH shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 25, 2026 | Theravance Biopharma, Inc. (TBPH) | Disposition to Issuer | 58,065 | n/a |
| Jun 17, 2026 | Theravance Biopharma, Inc. (TBPH) | Grant/Award | 6,009 | n/a |
| May 26, 2026 | Karyopharm Therapeutics Inc. (KPTI) | Grant/Award | 15,508 | n/a |
| Feb 27, 2026 | Mereo BioPharma Group plc (MREO) | Grant/Award | 66,000 | n/a |
| May 29, 2025 | Karyopharm Therapeutics Inc. (KPTI) | Grant/Award | 4,600 | n/a |
| May 21, 2025 | Theravance Biopharma, Inc. (TBPH) | Grant/Award | 10,649 | n/a |
| Feb 6, 2025 | Mereo BioPharma Group plc (MREO) | Grant/Award | 55,000 | n/a |
| Aug 23, 2024 | Mereo BioPharma Group plc (MREO) | Exercise/Conversion | 1,825 | $5.5K |
| Jun 7, 2024 | Karyopharm Therapeutics Inc. (KPTI) | Sale | 463,518 | $444.1K |
| Jun 4, 2024 | Karyopharm Therapeutics Inc. (KPTI) | Sale | 202,418 | $193.1K |